Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 2/20 | 0.35 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.31 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.31 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.31 |
| ▸ | PIM1 | P11309 | 1/20 | 0.31 |
| ▸ | PLK1 | P53350 | 1/20 | 0.31 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.31 |
| ▸ | CDC42BPA | Q5VT25 | 1/20 | 0.31 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.31 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.31 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19973228 | 0.86 | CA12 (0.32) | CA12CA1CA2MMP2CA9 | |
| SCHEMBL19973209 | 0.77 | CA12 (0.37) | CA12CA1CA2MMP2CA9 | |
| SCHEMBL19973306 | 0.74 | CA12 (0.35) | CA12CA1CA2MMP2CA9 | |
| SCHEMBL19973248 | 0.71 | CA12 (0.33) | CA12CA1CA2MMP2CA9 | |
| SCHEMBL14797927 | 0.70 | CA12 (0.40) | CA12CA1CA2MMP2CA9 | |
| SCHEMBL19973242 | 0.66 | CA12 (0.34) | CA12CA1CA2MMP2CA9 | |
| SCHEMBL16628347 | 0.65 | CA12 (0.37) | CA12CA1CA2MMP2CA9 | |
| SCHEMBL6557485 | 0.65 | CA12 (0.47) | CA12CA1CA2MMP2CA9 | |
| SCHEMBL23020214 | 0.64 | CA12 (0.45) | CA12CA1CA2MMP2CA9 | |
| SCHEMBL22924338 | 0.64 | CA12 (0.45) | CA12CA1CA2MMP2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3516089-B1 | COMPOSITIONS AND METHODS FOR THE DEPOSITION OF SILICON OXIDE FILMS | VERSUM MAT US LLC (US) | 2023-12-20 | — | — | EP | claimed |
| US-11584854-B2 | Compositions and methods for the deposition of silicon oxide films | VERSUM MATERIALS US, LLC (US) | 2023-02-21 | — | — | US | claimed |
| CN-113403605-A | Compositions and methods for depositing silicon oxide films | 弗萨姆材料美国有限责任公司 | 2021-09-17 | — | — | CN | claimed |
| US-20200308416-A1 | Compositions And Methods For The Deposition Of Silicon Oxide Films | VERSUM MATERIALS US, LLC (US) | 2020-10-01 | — | — | US | claimed |
| US-20200040192-A9 | Compositions and Methods for the Deposition of Silicon Oxide Films | VERSUM MATERIALS US, LLC (US) | 2020-02-06 | — | — | US | claimed |
| EP-3516089-A1 | COMPOSITIONS AND METHODS FOR THE DEPOSITION OF SILICON OXIDE FILMS | Versum Materials US, LLC (US) | 2019-07-31 | — | — | EP | claimed |
| US-20180127592-A1 | Compositions and Methods for the Deposition of Silicon Oxide Films | VERSUM MATERIALS US, LLC (US) | 2018-05-10 | — | — | US | claimed |
| WO-2018053129-A1 | COMPOSITIONS AND METHODS FOR THE DEPOSITION OF SILICON OXIDE FILMS | VERSUM MATERIALS US, LLC (US) | 2018-03-22 | — | — | WO | claimed |
| EP-3516089-B1 | COMPOSITIONS AND METHODS FOR THE DEPOSITION OF SILICON OXIDE FILMS | VERSUM MAT US LLC (US) | 2023-12-20 | — | — | EP | disclosed |
| CN-113403605-A | Compositions and methods for depositing silicon oxide films | 弗萨姆材料美国有限责任公司 | 2021-09-17 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308416-A1 | Compositions And Methods For The Deposition Of Silicon Oxide Films | SEPTIN9, SGMS1, SGMS2 | CA12 62/4885CA1 42/4885CA2 1042/4885 |
| US-20180127592-A1 | Compositions and Methods for the Deposition of Silicon Oxide Films | SEPTIN9, SGMS1, SGMS2 | CA12 62/4885CA1 42/4885CA2 1042/4885 |
| US-20200040192-A9 | Compositions and Methods for the Deposition of Silicon Oxide Films | SEPTIN9, SGMS1, SGMS2 | CA12 62/4885CA1 42/4885CA2 1042/4885 |
| US-11584854-B2 | Compositions and methods for the deposition of silicon oxide films | SEPTIN9, SGMS1, SGMS2 | CA12 62/4885CA1 42/4885CA2 1042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.